SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-013842
Filing Date
2023-04-21
Accepted
2023-04-21 16:11:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A updated_beam_2023_notice.htm DEFA14A 43722
2 GRAPHIC img242705548_0.jpg GRAPHIC 541474
3 GRAPHIC img242705548_1.jpg GRAPHIC 388717
  Complete submission text file 0000950170-23-013842.txt   1325429
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39208 | Film No.: 23836477
SIC: 2836 Biological Products, (No Diagnostic Substances)